Release Date: 22/04/21 08:26 Summary: Positive FDA Pre-IND meeting guides IHL-675A development Price Sensitive: Yes Download Document 186.96KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%